What is he best known for?
The fields of study he is best known for:
His primary areas of investigation include Cancer research, Myeloid leukemia, Leukemia, Stem cell and Progenitor cell.
His research in the fields of Imatinib mesylate overlaps with other disciplines such as Oligodendrocyte Transcription Factor 2.
Xiaoyan Jiang performs multidisciplinary studies into Myeloid leukemia and Interleukin 3 in his work.
The Leukemia study combines topics in areas such as CD34 and Autocrine signalling.
His Stem cell research integrates issues from Chronic myelogenous leukemia and Philadelphia chromosome.
As a part of the same scientific family, Xiaoyan Jiang mostly works in the field of Haematopoiesis, focusing on Autophagy and, on occasion, Physiology.
His most cited work include:
- Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition) (4170 citations)
- Isolation of a highly quiescent subpopulation of primitive leukemic cells in chronic myeloid leukemia. (459 citations)
- Chronic myeloid leukemia stem cells possess multiple unique features of resistance to BCR-ABL targeted therapies. (317 citations)
What are the main themes of his work throughout his whole career to date?
His primary scientific interests are in Cancer research, Stem cell, Progenitor cell, Myeloid leukemia and CD34.
The study incorporates disciplines such as Tyrosine kinase, Leukemia, K562 cells and Bone marrow in addition to Cancer research.
His studies in Leukemia integrate themes in fields like Cancer stem cell, Autocrine signalling and Drug resistance.
The various areas that Xiaoyan Jiang examines in his Stem cell study include Molecular biology, Immunology and Imatinib mesylate.
His Progenitor cell study incorporates themes from Autophagy, microRNA and Tyrosine-kinase inhibitor.
His Myeloid leukemia research is multidisciplinary, incorporating elements of Gene silencing, Philadelphia chromosome and Small interfering RNA.
He most often published in these fields:
- Cancer research (69.17%)
- Stem cell (45.85%)
- Progenitor cell (42.29%)
What were the highlights of his more recent work (between 2018-2021)?
- Cancer research (69.17%)
- Myeloid leukemia (37.15%)
- Progenitor cell (42.29%)
In recent papers he was focusing on the following fields of study:
Xiaoyan Jiang focuses on Cancer research, Myeloid leukemia, Progenitor cell, Internal medicine and Ageing.
His Cancer research research is multidisciplinary, relying on both Apoptosis, Cancer stem cell, Stem cell, Leukemia and Drug resistance.
In Stem cell, Xiaoyan Jiang works on issues like microRNA, which are connected to Cell culture and Growth factor.
Xiaoyan Jiang interconnects Tyrosine kinase, K562 cells and Kinase in the investigation of issues within Myeloid leukemia.
His research in Progenitor cell intersects with topics in Therapy resistant, Cell cycle and Xenotransplantation.
Xiaoyan Jiang works mostly in the field of SiRNA binding, limiting it down to topics relating to Cell biology and, in certain cases, Autophagy, as a part of the same area of interest.
Between 2018 and 2021, his most popular works were:
- Current Outlook on Autophagy in Human Leukemia: Foe in Cancer Stem Cells and Drug Resistance, Friend in New Therapeutic Interventions. (17 citations)
- Current outlook on drug resistance in chronic myeloid leukemia (CML) and potential therapeutic options. (11 citations)
- Frailty phenotype, frailty index and risk of mortality in Chinese elderly population- Rugao longevity and ageing study. (9 citations)
In his most recent research, the most cited papers focused on:
Xiaoyan Jiang mainly focuses on Cancer research, Myeloid leukemia, Tyrosine kinase, Imatinib and K562 cells.
His work on Leukemia expands to the thematically related Cancer research.
In his research, Autophagy, Drug, Disease and Cytotoxic T cell is intimately related to Drug resistance, which falls under the overarching field of Leukemia.
His Imatinib research is multidisciplinary, incorporating perspectives in Gene silencing and Protein kinase B.
Xiaoyan Jiang has researched Gene silencing in several fields, including Jurkat cells, Small interfering RNA, Oncogene, Genetic enhancement and Tyrosine-kinase inhibitor.
Xiaoyan Jiang has included themes like breakpoint cluster region, Stem cell, Kinase and Focal adhesion in his ABL study.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
